로그인  |   회원가입  |   ID/PW 찾기   |  제품상담문의  
  • 고객지원 
  • 업무안내│제품문의
  • 전화번호│02-2081-2510
  • Email     │support@takara.co.kr
  • 대전지사 
  • 업무안내│대전/충청지역 주문, 제품문의
  • 전화번호│042-828-6525
  • Email     │tkbd@takara.co.kr
  • 업무시간안내
  • [ 평  일 ] 09 : 00 ~ 18 : 00 │ [ 점심시간 ] 12 : 00 ~ 13 : 00
  • 토·일요일, 공휴일은 휴무입니다.

 제목 : [다카라공시] 스마트폰 어플을 이용한 rapid lentivirus test 제품 출시
작성일 : 2018.05.23
 작성자 : 다카라코리아


A leading biotechnology company has developed a rapid test to measure recombinant lentivirus titers using a smartphone as a diagnostic reader.

Takara Bio USA, Inc. (TBUSA; formerly Clontech Laboratories, Inc.) teamed up with smartphone diagnostics specialists, Novarum DX, to develop an integrated, mobile platform which detects and quantifies recombinant lentivirus in packaging cell supernatants.

Novarums next generation diagnostic technology transforms a smartphone into a test reader to rapidly deliver accurate results without the need for large or expensive instrumentation.

Working with Novarum, TBUSA developed a new Lenti-X GoStix Plus app which is used in conjunction with the companys Lenti-X GoStix Plus lateral flow test. The GoStix cassette detects the presence of lentiviral p24 protein, and titer is quantified using a smartphone camera.

Lentiviral vectors have proven to be powerful tools for stable gene transfer to both dividing and non-dividing cells in vitro and in vivo. Until now, tests for measuring lentivirus titer were complicated and convoluted—it could take several hours to days, depending on the method used, to deliver only a single quantitative result. Applying Novarums patented image-capture technology now enables Takara Bios rapid tests to provide accurate, quantitative lentivirus titers in only ten minutes with virtually no effort.

The Lenti-X GoStix Plus app provides intuitive step-by-step instructions, including alarm and timer features, to ensure tests are performed correctly. Up to four tests can be run simultaneously, using a single ten-minute timer, and the results are scanned sequentially. QR codes, labelled on the GoStix foil pouches, can also be scanned to identify lot numbers for facilitating batch calibration and quantification.

Baz Smith, Associate Director, Gene Function Marketing at TBUSA, said, "Takara Bio is committed to doing good science that supports biotechnology research around the world. Working with Novarum, our pioneering Lenti-X GoStix Plus app has been successfully launched on both GooglePlay and the AppStore, for Android and Apple devices, respectively. Were proud of the positive feedback and the app store ratings weve already received from early adopters of our ground-breaking technology."

Dr Neil Polwart, founder of Novarum and BBI Group Head of Mobile, said, "Our team has worked alongside Takara Bio to create a lateral flow reader and mobile app which enhances lentivirus testing. Its incredibly exciting to witness how our next-generation technology is challenging the accepted norms with improved efficiency and innovation."

Acquired by BBI Solutions in 2016, Novarum has revolutionised diagnostics by transforming a smartphone into a test reader. The results of disposable tests for toxicology, infectious or auto-immune disease are accurately read and shared securely via a dedicated portal, which is accessible online. For more information on Novarum, visit: www.novarumdx.com.

Takara Bio USA, Inc., (TBUSA; formerly Clontech Laboratories, Inc.) is a wholly owned subsidiary of Takara Bio Inc. that manufactures and distributes kits, reagents, and instruments for life sciences research applications, including NGS, PCR, gene delivery, genome editing, stem cell research, nucleic acid and protein purification, and automated sample preparation